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Structure of Mycobacterium 
thermoresistibile GlgE defines 
novel conformational states 
that contribute to the catalytic 
mechanism
Vitor Mendes1,2, Michal Blaszczyk1, Ana Maranha2, Nuno Empadinhas2 & Tom L. Blundell1
GlgE, an enzyme of the pathway that converts trehalose to α-glucans, is essential for  
Mycobacterium tuberculosis. Inhibition of GlgE, which transfers maltose from a maltose-1-phosphate 
donor to α-glucan/maltooligosaccharide chain acceptor, leads to a toxic accumulation of maltose-1-
phosphate that culminates in cellular death. Here we describe the first high-resolution mycobacterial 
GlgE structure from Mycobacterium thermoresistibile at 1.96 Å. We show that the structure resembles 
that of M. tuberculosis and Streptomyces coelicolor GlgEs, reported before, with each protomer in 
the homodimer comprising five domains. However, in M. thermoresistibile GlgE we observe several 
conformational states of the S domain and provide evidence that its high flexibility is important for 
enzyme activity. The structures here reported shed further light on the interactions between the 
N-terminal domains and the catalytic domains of opposing chains and how they contribute to the 
catalytic reaction. Importantly this work identifies a useful surrogate system to aid the development 
of GlgE inhibitors against opportunistic and pathogenic mycobacteria.
Mycobacteria comprise a diverse group of organisms, many of which are known human pathogens. The 
most notorious member of this genus is undoubtedly Mycobacterium tuberculosis, the major causative 
agent of tuberculosis (TB), a disease that remains a leading cause of mortality worldwide, claiming an 
estimated 1.5 million lives in 20131. Furthermore, infections by opportunistic non-tuberculous myco-
bacteria (NTM) are increasing worldwide due to their colonization of man-made environments, such as 
water distribution systems, and their intrinsic detergent and drug resistance that allows them to flourish 
in hospital environments2.
Despite available treatments the rapid emergence of multi-drug and extensively-drug-resistant strains, 
together with a deadly synergy with HIV, has severely limited our capacity to control and eradicate TB. 
The combination of the recent increase of NTM infections with the appearance of totally drug-resistant 
TB strains3 makes the finding of new tools to develop new drugs against these organisms a priority.
GlgE is a maltosyl transferase that transfers maltose from a maltose-1-phosphate (maltose-1P) donor 
to α -(1–4) glucan chains4,5. This enzyme is part of a pathway involving three other enzymes, trehalose 
synthase (TreS), maltokinase (Pep2/Mak) and glycogen branching enzyme (GlgB), which link trehalose 
recycling to glycogen and other branched α -glucans synthesis4–6. GlgE is essential for M. tuberculosis 
and its depletion leads to pleiotropic stress effects and eventually cell death4. Interestingly, cell death 
is associated with substrate (maltose-1P) hyper-accumulation, and not with the absence of product, 
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since there are at least two other pathways in M. tuberculosis that lead to glycogen and other α -glucan 
synthesis4,7. There appears to be complex crosstalk between the GlgE pathway, Rv3032 of the methyl 
glucose lipopolysaccharide (MGLP) pathway, and glycogen synthase/glucose-1-phosphate adenylyltrans-
ferase (GlgA/GlgC) classical glycogen pathway4,8,9, with a synthetic lethal interaction being reported for 
TreS and Rv30324. This crosstalk seems to be at least partially regulated by phosphorylation, with ser-
ine/threonine protein kinase PknB playing a significant role in regulating GlgE activity10. Additionally, 
the TreS-Pep2-GlgE-GlgB pathway is distributed almost exclusively in bacteria, with rare exceptions in 
archaea and with no known GlgE orthologues in eukaryotes7. The combined essentiality of GlgE with the 
lack of orthologues in humans makes it a very attractive target for TB drug discovery.
GlgE belongs to the glycosyl hydrolase GH13_3 family11. GH13 enzymes exhibit a conserved 
three-domain core usually designated by A, B and C12. Domain A is a (β /α )8 barrel, while a small domain 
of variable size (domain B) is inserted between β 3 and α 3 of domain A13. Domain C is a β -sandwich 
domain located at the C-terminus13. The active site of GH13 enzymes is found in a cleft between domains 
A and B14. The structure of Streptomyces coelicolor, GlgE isoform I, a 5-domain enzyme forming a dimer, 
exhibits the typical GH13 core domains with two extra domains at the N-terminus: an α -helix bundle 
and a second β -sandwich domain15.
GlgE is proposed to catalyse the transfer of maltosyl units to α -glucan chains through a 
double-displacement reaction in which an aspartate residue acts as a nucleophile forming an 
β -maltosyl-enzyme intermediate, while a glutamate residue is thought to protonate the phosphate and 
deprotonate the acceptor, acting like an acid/base catalytic residue16. Furthermore, the first GlgE inhib-
itors have been reported recently17,18 and the first low resolution M. tuberculosis GlgE structures have 
just become available19.
We here report the first high-resolution X-ray analyses of a mycobacterial GlgE, defining a maltose-GlgE 
complex of Mycobacterium thermoresistibile GlgE, as well as the apo form and a new conformational state 
obtained by co-crystallizing GlgE with maltose-1P. We show that M. thermoresistibile GlgE structure 
resembles that of S. colelicolor and M. tuberculosis GlgEs with each protomer in the dimer comprising 
five domains, but in M. thermoresistibile GlgE we observe several conformational states of the S domain 
that point towards considerable flexibility and shed further light on its role in the catalytic mechanism.
Results
Kinetic properties of M. thermoresistible GlgE. We first determined kinetic parameters in order 
to compare enzyme properties with M. tuberculosis and with S. coelicolor GlgE, the only orthologous 
structures available to date. As with M. tuberculosis and S. coelicolor GlgE4,15, M. thermoresistibile GlgE 
uses maltose-1P exclusively as a maltosyl donor. M. thermoresistible GlgE KM and kcat values are com-
parable to those of orthologues from M. tuberculosis and S. coelicolor GlgE (Table  1), with KM values 
of 0.29 ± 0.04 mM for maltose-1P in the presence of 1 mM maltohexaose and of 7.09 ± 0.94 mM for 
maltoheaxose in the presence of 5 mM maltose-1P (Supplementary Fig. S1). Both calculated constants 
are in line with previous observations in M. smegmatis when glycogen was used as a maltosyl acceptor5.
M. thermoresistibile GlgE overall structure. The three different structures obtained in this study 
with resolution limits ranging from ~2.0 to ~3.3 Å were GlgE apo-form (5CJ5), GlgE-maltose com-
plex (5CGM) and a second GlgE-maltose complex (5CIM) obtained by co-crystallizing with GlgE with 
maltose-1P. Of the three different tags (C-terminal non-cleavable 6xHis Tag, N-terminal non-cleavable 
6xHis Tag and N-terminal cleavable SUMO tag) used, the construct with an N-terminal cleavable SUMO 
tag produced the best diffracting crystals and was used to obtain crystals in all conditions. However, 
we could only obtain high-resolution crystals (~2.0 Å) when GlgE was co-crystalized with maltose, 
maltohexaose or both. Apo-form crystals and GlgE-maltose-1P co-crystallizations always produced 
crystals that diffracted to lower resolutions (< 3 Å) despite all optimization efforts. The maltohexaose 
and maltose co-crystallizations produced indistinguishable structures in which only maltose could be 
observed at the active site. This was not unexpected since others have reported that GlgE slowly degrades 
Enzyme Substrate Km (mM) kcat (s−1) kcat/Km (M−1s−1)
M. thermoresistibile
Maltose-1Pa 0.29 ± 0.04 4.06 ± 0.11 14000 ± 2800
Maltoheaxaosea 7.09 ± 0.94 49.91 ± 1.73 7000 ± 1800
M. tuberculosis
Maltose-1Pb 0.25 ± 0.05 1.26 ± 0.07 5000 ± 1000
Maltosehexaoseb 35 ± 8 15.4 ± 1.1 440 ± 100
S. coelicolor Isoform I
Maltose-1Pc 0.30 ± 0.06 12.3 ± 0.5 41000 ± 8000
Maltohexaosec 1.5 ± 0.3 53 ± 2 36000 ± 7000
Table 1.  Comparison of kinetic parameters between M. thermoresistibile, M. tuberculosis and  
S. Coelicolor GlgEs. aThis study. bObtained from4. cObtained from15.
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maltooligosaccharides to maltose in the time scale required for crystallization15. Therefore we present 
only the highest resolution structure obtained in these conditions.
The structure of M. thermoresistible GlgE was solved by molecular replacement at 1.96 Å (see meth-
ods) and refined with a final R-factor of 0.175 and Rfree of 0.203 (Table 2). This model proved useful for 
solving the structures of apo form and maltose-1P co-crystallization condition by molecular replacement 
at 3.13 and 3.32 Å respectively. Both structures have been refined to acceptable statistics (Table 2).
M. thermoresistibile GlgE forms a dimer in all obtained structures and in solution, a feature reported 
previously for GlgE in other studied organisms4,5,15. Each of the protomers of M. thermoresistibile GlgE 
contains 5 domains and 2 inserts (Fig. 1) that have been described extensively in the first reported GlgE 
structure15 and therefore we will focus on the particular characteristics of M. thermoresistibile GlgE. The 
N-terminal, domain N is a β -sandwich domain, responsible for the majority of dimerization contacts and 
interacting directly with the catalytic domain of the adjacent protomer. This domain contains a very long 
loop of 36 residues, connecting β -strands 4 and 5 of this domain, part of which (residues 71–86) has no 
observable density and therefore was not modelled. This loop is highly variable both in length and amino 
acid composition even among closely related mycobacterial species (Supplementary Fig. S2). Domains S 
and B also contribute to the dimer interface but to a lesser extent (Fig. 1 and Fig. 2A). Domain A and 
B together with inserts 1 and 2 form the catalytic unit. The C-terminal domain (domain C), a second 
β -sandwich domain, is not directly involved in catalytic activity but sits on top of the catalytic domain A, 
as reported before in S. coelicolor GlgE15. A C-terminal short α -helix in the M. thermoresistibile domain 
C, which contacts domain N, is found in all other mycobacterial GlgEs but is not found in that of S. 
coelicolor (Supplementary Fig. S2). Domain C together with domain A were recently shown to to be 
Dataset Maltose Maltose-1-P APO
Data collectiona
 Beamline at DLS I04–1 I04 I24
 Wavelength (Å) 0.92 0.979 0.978
 Space group P212121 P212121 P6
 Unit cell dimensions (Å)
a = 80.33; 
b = 113.90; 
c = 220.50
a = 77.5; b = 112.9; 
c = 221.4
a = b = 197.64; 
c = 105.62
 Resolution range (Å) 54.3–1.92 (2.02–1.92)
221.4–3.32 
(3.50–3.32)
171.2–3.13 
(3.30–3.13)
 Reflections (measured/unique) 147,668/10,554 149,129/28,988 563,574/41.587
 Completeness (%) 99.9 (99.9) 99.8 (99.8) 99.7 (99.7)
 Multiplicity 12.8 (13.7) 10.9 (8.6) 13.5 (13.6)
 Rsymb 0.065 (0.690) 0.083 (0.595) 0.218 (1.541)
 Mean [(I)/σ (I)] 11.4 (2.44) 5.0 (5.2) 13.0 (2.3)
 Protomers per asymmetric unit 2 2 2
 Matthews coefficient (Å3 Da−1) 3.25 3.26 3.47
 Solvent content (%) 62.1 62.5 67.4
Refinement
 Resolution range (Å) 37.74–1.95 100.6–3.32 57.06–3.13
 Rfactorc/Free Rfactord(%) 17.5/20.2 17.8/21.4 25.9/30.8
  Unique reflections (working/
test set) 10,227/564 29,449/1494 41621/2093
 Water molecules 934 116 0
 Total number of atoms 11650 10246 10489
 r.m.s.d. bond lengths (Å) 0.010 0.010 0.013
 r.m.s.d. bond angles (°) 0.990 1.210 1.832
Ramachandran plot statistics
 Residues in allowed regions (%) 97.1 93.1 90.4
Table 2.  Data collection and refinement statistics. aValues in parenthesis correspond to the outermost 
resolution shell. bRsym = ∑h∑i |Ii(h)-‹I(h)›|/∑h∑i Ii(h), where I is the observed intensity and ‹I› is the average 
intensity of multiple observations of symmetry-related reflections. cRfactor = ∑||Fo|-|Fc||/∑|Fo| where |Fo| and 
|Fc| are observed and calculated structure factor amplitudes, respectively. dFree Rfactor is the cross-validation 
Rfactor computed for a randomly chosen subset of 5% of the total number of reflections, which were not used 
during refinement.
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involved in the binding of α -glucan chains19. Although the identified binding patch in the surface of 
the protein is not 100% conserved there is a high degree of conservation among mycobacterial species 
(Supplementary Fig. S2).
In the maltose co-crystallization structure (5CGM) several ethylene glycol molecules and polyethyl-
ene glycol chains of different sizes are visible due to PEG300 being present in the crystallization condi-
tion at high concentration (30%). Two phosphate groups can also be seen bound to each of the chains 
sitting in a groove between domain N and the terminal α -helix of C. Two other phosphate groups sit in 
a positively charged patch formed by domains A and N of the two opposing protomers, near the active 
site. Interestingly all the phosphate groups are close to threonines, T98 for the first duo and T445 for 
the second (Fig. 3).
The apo form structure (5CJ5) is similar to the maltose-containing structure, with the most signifi-
cant differences occurring in domains S and C where shifts are observed of ~4.3 and ~7.5 Å respectively 
(Supplementary Fig. S3). However, apo-form crystals diffracted at a much lower resolution than the 
maltose co-crystallization condition. Electron density cannot be distinctively seen for residues 598–603, 
621–635 and 663–669 of the domain C of chain A in this structure due to direct neighbouring with 
symmetry element. The same residues are clearly visible in Chain B where the β -sandwich fold of domain 
C is seen intact.
Catalytic site. The active site of GlgE sits at the TIM-barrel domain, but domain B together with 
inserts 1 and 2 are also part of the active site15 (Fig. 2B). From the maltose-bound structure, which is the 
highest resolution structure reported in this work, we can see that the donor substrate forms hydrogen 
bonds with the side chains of the highly conserved K283, N287 and S298 of the insert 1. Interestingly 
S298 is not conserved in S. coelicolor GlgE, where it is replaced by a valine, but conservation of serine 
occurs in all mycobacteria and in almost all other GlgEs. This serine forms hydrogen bonds with the C6 
hydroxyl group (~2.8 Å) and the ring oxygen (~3.1 Å) of the non-reducing glucose. K283 forms hydrogen 
bonds with the C3 and C4 hydroxyl groups and N287 with C2 hydroxyl group, all from the non-reducing 
glucose. The donor substrate further interacts with the side chains of the absolutely conserved Q343 and 
D378 of domain B, R411, D413, E442 and D498 of domain A and K552 and Y553 of insert 2 (Fig. 2B). 
Three other residues (N371, Y376 and N414) have been shown previously to form hydrogen bonds with 
the phosphate group16. Although in this work we did not obtain a structure with intact maltose-1P (see 
below), these three residues are present in all mycobacterial GlgEs and conserved in all GlgE sequences.
Maltose-1P-GlgE co-crystallization. In an attempt to obtain a maltosyl-GlgE intermediate state, 
GlgE was co-crystalized with maltose-1P. We could not observe the maltosyl-GlgE intermediate but 
instead we found maltose bound to only one of the active sites of the dimer (Fig. 4). The fact that maltose 
was present instead of maltose-1P is most likely due to GlgE slowly degrading maltose-1P to maltose, 
since maltose-1P was free of maltose contamination and we confirmed its stability at different tempera-
tures for long periods of time (Supplementary Fig. S4). Moreover others have also reported slow degrada-
tion of maltose-1P by S. coelicolor GlgE during the crystallization time span15. Significant conformational 
changes were however visible in the structure especially in the S domain of the protomer with bound 
maltose (Fig. 3B and Supplementary Fig. S5A). The S domain of this protomer exhibits conformational 
changes with several residues of α 1 (V132–L136) and α 2 (S146–150) losing their helical conformation 
(Fig. 3B). These residues are those closer to loop 2 of domain B of the “apo” protomer and the observed 
changes can indicate differences in the contacts between these two domains (Supplementary Fig. S5A). 
Moreover, all four helices comprising the S domain of the maltose-bound protomer were found to be 
Figure 1. (A) Cartoon representation of the overall structure of M. thermoresistibile GlgE. Loops have been 
simplified for clarity. Domains N consists of residues 1–122 and 205–220, domain S 123–204, domain A 
221–273, 319–340, 387–530 and 569–590, domain B 341–386, domain C 591–696, insert 1 274–318 and 
insert 2 531–568. (B) Cartoon representation of M. thermoresistibile GlgE dimer. Figure was prepared with 
Pymol (http://www.pymol.org).
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shifted with a maximum distance of ~6.5 Å when compared to both the maltose co-crystallization and 
the apo structure. This brings domain S of the maltose containing protomer closer to loop 2 of domain B 
of the “apo” protomer (Fig. 3). These observations imply a mechanism where domain S of one protomer 
interacts with loop 2 of domain B of the opposing protomer to move the antiparallel β -strand lid that 
covers the active site into an open or closed conformation, allowing the substrate/product to enter/leave 
the active site. Unfortunately, the majority of domain B, including loop 2 and the antiparallel β -strand 
lid, is not seen clearly in the maltose-1P co-crystallization structure “apo-protomer” and thus it could 
not be modeled (Fig. 4 and Supplementary Fig. S5A).
Discussion
The overall structure of the M. thermoresistibile GlgE is very similar to the previously reported struc-
tures of M. tuberculosis and S. colelicolor GlgEs15,19 with each of the protomers in the dimer compris-
ing five domains (Supplementary Fig. S5B). The major structural differences between the mycobacterial 
and the S. coelicolor structures occur in the relative positions of the S domain helices and in the pres-
ence of an extra C-terminal alpha helix in mycobacterial GlgEs. Although in the previously reported 
S. coelicolor and M. tuberculosis GlgE structures15,16,19,20 no significant differences are observed between 
ligand-bound structures and apo form, in our M. thermoresistibile GlgE structures we observe several 
Figure 2. (A) Close view of domain B and S of opposing protomers of M. thermoresistibile GlgE with 
maltose bound. (B) View of the active site of M. thermoresistibile GlgE with maltose bound. Individual 
domains are represented in different colours. Dashed black lines represent hydrogen bonds. Subsites − 1 
and − 2 are highlighted (C) Difference electron density map “omit map” of maltose. This map was generated 
using the phases from the final model.
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conformational states indicating a large flexibility of the S domain that hinges at residues Gly122 and 
Glu207 (Fig. 3B). We could not obtain a maltosyl-GlgE intermediate when GlgE was co-crystallized with 
maltose-1P, due to the slow but continuous degradation of maltose-1P by GlgE15, even though our initial 
Figure 3. (A) View of M. tuberculosis GlgE phosphorylation sites mapped in M. thermoresistibile GlgE 
structure (5GCM). T46 and T186 are conserved in M. tuberculosis and M. thermoresistibile. S143 and S365 
are mutated to threonine in M. tuberculosis. A188 and M80 are mutated to serine in M. tuberculosis. The 
side chain of S143 and the loop where M80 is located were not modeled since electron density is poor 
in those regions. The putative phosphorylation site T98 and T445 are also highlighted. (B) Superposition 
of structures of maltose co-crystallization (5GCM), maltose-1P co-crystallization (5ICM) and apo form 
(5CJ5). The represented protomer of maltose-1P structure has maltose bound. Regions that lose helical 
conformation in the maltose-1P co-crystallization structure are highlighted in red.
Figure 4. Comparison of the active sites of chain A and B of the maltose-1P co-crystallization condition. 
Maltose is only present in chain B. The antiparallel β -strand lid and loop 2 of domain B are only visible in 
chain B.
www.nature.com/scientificreports/
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GlgE-maltose-1P ratio in the crystallization drop was ~1:60. To address this issue others have produced 
mutated S. coelicolor GlgE and used 2-deoxy-2-fluoro-α -maltosyl fluoride and have been successful in 
obtaining a structure of this intermediate state and also a maltose-1P-GlgE complex16. Nevertheless our 
co-crystallization with maltose-1P allowed us to obtain an intermediate state where only one of the pro-
tomers of the dimer contains maltose. The significant differences found between the two S domains (apo 
and maltose bound) (Fig. 3B) point to a mechanism where the S domain interacts with the domain B of 
the opposite protomer to open/close the antiparallel β -strand lid covering the active site. Unfortunately 
the majority of domain B, including loop 2 and some regions of insert one of the “apo” protomer in the 
maltose-1P co-crystallization structure (5CIM), could not be modelled due to lack of electron density 
(Supplementary Fig. S5A). This could be explained by an increased flexibility of the catalytic domain 
when in an open/relaxed state before binding of maltose-1P. These differences cannot be dismissed as 
crystallographic artefacts since both maltose and maltose-1P-co-crystallization structures were obtained 
in the same conditions and crystals belong to the same space group with same packing and similar unit 
cell dimensions (Table 2).
PknB, a serine/threonine protein kinase, was reported to play a fundamental role in regulating GlgE 
by substantially decreasing GlgE activity by phosphorylation of specific residues10. The phosphorylation 
sites have been mapped for M. tuberculosis GlgE, however not all of them are conserved in M. thermore-
sistibile (Supplementary Fig. S2). Amongst those not conserved two threonines are mutated to serine in 
M. thermoresistibile and it is likely that they will be phosphorylated by PknB. Nevertheless, the fact that 
two of them are located in domain S and one in loop 2 of domain B is consistent with an interaction of 
these two domains that is important for the catalytic activity of GlgE. Although it has been found that 
other Actinomycetes besides M. tuberculosis also phosphorylate GlgE and thus might regulate GlgE activ-
ity by phosphorylation10, it is interesting to note that many of the phosphorylation sites are not fully con-
served. This raises questions about the significance of the regulation of GlgE activity by phosphorylation 
in other species and whether there are other/different phosphorylation sites in those species. In the high 
resolution structure we are reporting (5GCM) we could observe four phosphate groups that are close to 
threonines. One of the threonines, T445 of domain A, sits close to the active site and within what could 
be the binding region of the acceptor substrate (Fig. 3A). This threonine is highly conserved in all myco-
bacteria species and even in closely related organisms (Supplementary Fig. S2). It is tempting to speculate 
that this threonine may also be subject to phosphorylation. Although phosphorylation has not been 
reported for this particular threonine by Leiba and colleagues, they have restricted their work to PknA 
to F10. Several other Pkn kinases are present in mycobacteria that could potentially phosphorylate GlgE.
Domain C is found in many other members of the GH13 family. It has been proposed to help stabilize 
the catalytic domain and it could also be involved in substrate binding in some cases21. Recently it was 
shown to be involved in α -glucan chain binding in GlgE19. The extra α -helix present in mycobacteria 
forms direct contacts with the first β -sandwich domain (domain N) and creates a small grove where 
we observe phosphate binding. This phosphate again interacts with another threonine, T98 in this case. 
This threonine belongs to the N domain but unlike T445 it is not conserved even within Mycobacterium 
genus. Nevertheless, other mycobacteria and closely related species have a threonine in the terminal 
α -helix of domain C that is surface exposed and could still form interactions with this phosphate, poten-
tially keeping it in the same area if these threonines would be phosphorylated by a yet unidentified 
kinase. These contacts and potential phosphorylations sites may also have some indirect influence on the 
catalytic activity mediated by the two β -sandwich domains. However we do not see major differences in 
this terminal α -helix between our three structures, nor do we see differences in the domain N that could 
give some indication of the structural effect of these putative phosphorylation site.
The global interactions with maltose in both donor subsites − 2 and − 1 are identical for mycobacte-
rial and S. coelicolor GlgE with the exception being only the presence of a serine in mycobacteria that is 
replaced by a valine in S. coelicolor. This serine forms hydrogen bonds with the C6 hydroxyl group of the 
non-reducing hexose ring and further contributes to the highly hydrophilic nature of the active site. To 
address this difference other groups have mutated this valine to serine in S. coelicolor active site to make 
it more similar to mycobacteria and have successfully used it has a surrogate system16,19,20.
Recently it was shown that several loops of domains A and C form a binding patch for linear α -glucan 
chains19. This patch is not totally conserved even when comparing GlgE sequences within mycobacteria 
(Supplementary Fig. S2). Nevertheless it was suggested that hydrogen bonds between the linear α -glucan 
chain and the backbone atoms are more important than side chain interactions19. This surface patch sits 
at 26 Å from the catalytic site and therefore it is not immediately involved in the catalytic reaction. It 
should however play an important role in orienting an α -glucan chain towards the catalytic site. Some 
questions still remain unanswered. The specific orientation and binding region as well as what defines 
specificity of the acceptor substrates are yet to be clarified and although we could see leftover density in 
maltohexaose co-crystallization structures only a few atoms of a third glucose ring could be modeled 
(data not shown).
GlgE confirmed essentiality in M. tuberculosis and lack of human orthologues makes it an attractive 
target for drug discovery. The structure we report here will allow more accurate models of this protein 
to be built for other mycobacteria particularly as no other high resolution mycobacterial structures are 
available to date. The observations that kinetic constants are intermediate between those found for M. 
tuberculosis and S. coelicolor GlgEs and 100% sequence identity at the active site when compared with 
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other mycobacterial GlgEs indicate that it can be used as a good surrogate system for target-based drug 
discovery in these organisms.
Methods
Bacterial strains and cloning. The glgE gene was amplified from chromosomal DNA of M. thermore-
sistibile (DSM 44167) obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen 
GmbH (DSMZ, Braunschweig, Germany), with primers based on the sequence retrieved from NCBI 
database. A BamHI restriction site was added to the forward primer 5′ -TAAGGATCCGTGGCCGGTC
GGATCGTGATC-3′ and a HindIII restriction site to the reverse primer 5′ -ATTAAGCTTTCACTCCC
TGCGCAGCAGTTGC-3′ . After amplification, glgE was cloned in a pET28a vector (Novagen), modified 
with an N-terminal 6xHis-SUMO tag, and transformed into E. coli BL21(DE3) strain (Invitrogen). The 
resulting recombinant plasmid was verified by DNA sequencing.
Recombinant overexpression and protein purification. Transformed E. coli BL21(DE3) cells 
were grown to mid-exponential growth phase (OD610 = 0.8) in LB media, containing 30 mg L−1 kana-
mycin at 37 °C. Isopropyl β –D-1-thiogalactopyranoside (IPTG) was then added at a final concentration 
of 0.5 mM to induce gene expression and the temperature was lowered to 18 °C. Cells were harvested 
18 h–20 h later by centrifugation and re-suspended in 50 mM bis-tris propane (BTP) pH 7.2, 0.5 M NaCl 
and 20 mM imidazole with protease inhibitor tablets (Roche), DNAseI and 5 mM MgCl2. Cells were lysed 
with an emulsiflex (Avestin) and cell lysate was centrifuged at 27000 g for 30 mins to remove cell debris.
Recombinant M. thermoresistibile GlgE was purified with a HiTrap IMAC Sepharose FF column 
(GE-Healthcare), equilibrated with 50 mM BTP pH 7.2, 0.5 M NaCl and 20 mM imidazole. Elution was 
performed in the same buffer with 500 mM imidazole that was subsequently removed with a desalting 
column followed by SUMO tag overnight cleavage at 4 °C, by adding Ulp1 Protease at 1:100 ratio in 
20 mM BTP pH 7.2, 0.5 M NaCl. SUMO tag, Ulp1 protease and uncleaved SUMO-GlgE were removed 
with a HiTrap IMAC Sepharose FF column (GE-Healthcare), equilibrated with 20 mM BTP pH 7.2, 
0.5 M NaCl, 20 mM imidazole. Flow through containing GlgE was collected, concentrated and loaded 
on a Superdex 200 column equilibrated with 20 mM BTP pH 7.2 and 200 mM NaCl. Fraction purity was 
determined by SDS-page and purest fractions were pooled, concentrated to ~14.5 mg.ml−1 in 20 mM BTP 
pH 7.2 100 mM NaCl, flash frozen in liquid nitrogen and stored at − 80 °C.
Characterization of recombinant M. thermoresistibile GlgE. Reaction mixtures containing 
pure recombinant GlgE (0.05–0.5 μ M), maltoheaxaose, maltose-1P and 100 mM NaCl in 100 mM BTP 
buffer pH 7, were incubated at 37 °C and stopped at different time points. Activity was determined by 
the release of free phosphate, with a quantitative end point assay, using the Ames method22. Kinetic 
parameters were calculated by measuring rates of reaction using a range of substrate concentrations 
(0.25–10 mM for maltose-1P and 0.5–100 mM for maltoheaxaose). Pure maltose-1P was obtained from 
ExtremoChem. Data were fitted to the Michaelis-Menten equation using a least squares fitting in Prism 
5 (GraphPad Software). All experiments were performed in triplicate.
Crystallization and X-Ray data Collection. GlgE crystallization screens and optimization were per-
formed using the sitting-drop vapour diffusion method at 291 K with a protein concentration of ~7 mg/ml. 
Initial crystallization conditions for apo form were obtained from a PACT premier crystallization screen 
(Molecular Dimensions) solution H12, using an Art Robbins Phoenix crystallization robot by mix-
ing 0.3 μ l of protein solution and 0.3 μ l well solution. GlgE-ligand complex crystals were obtained in 
JCSG-plus crystallization screen (Molecular Dimentions) solution C6, using the same protein and well 
volumes as above but incubating GlgE solution with 5 mM maltose for 30 mins prior to setup crystal-
lization. The optimized conditions consisted of PEG3350 20% (v/v), 0.2 M sodium malonate and 0.1 M 
BICINE buffer pH 9.5 (apo form) and PEG 300 35% (v/v) and 0.1 M sodium phosphate/citrate buffer pH 
4.0 (GlgE-ligand complexes). Other ligands (maltohexaose and maltose-1P) were co-crystallized under 
the same conditions using ligand concentrations of 5 mM. Crystals were flash frozen in liquid nitrogen 
and stored for data collection at stations I04, I04–1 and I24 at Diamond Light Source (Oxford, UK). Data 
collection and refinement statistics are summarized in (Table 2).
Structure determination and refinement. Diffraction data were processed using MOSFLM23 and 
Aimless24 from the CCP4 suite25 or autoPROC from Global Phasing Limited26. GlgE-ligand complexes 
crystallized in P212121 spacegroup, while apo crystals belonged to P6 spacegroup, both with one dimer 
per asymmetric unit. Analysis with Pointless27 suggested that apo form crystallized in P6322 spacegroup, 
however L-test suggested twinning. XTRIAGE from PHENIX software package28 indicated that the crys-
tals were merohedraly twinned with operator h,-h-k,-l and therefore belonged to a lower symmetry 
spacegroup. Initial phases were determined with PHASER29 from PHENIX software package28 using 
the structure of S. coelicolor GlgE (PDB entry 3ZSS)15 as a search model. Model building was done with 
Coot30 and refinement was performed in PHENIX28. Structure validation was performed using Coot and 
PHENIX tools28,30. Refined coordinates and structure factors have been deposited in PDB with the acces-
sion numbers 5CJ5 (apo form), 5CGM (GlgE-maltose co-crystallization) and 5CIM (GlgE-maltose-1P 
co-crystallization).
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